Steensma, David P. http://orcid.org/0000-0001-5130-9284
Wermke, Martin http://orcid.org/0000-0002-4844-4087
Klimek, Virginia M.
Greenberg, Peter L.
Font, Patricia
Komrokji, Rami S. http://orcid.org/0000-0002-1876-5269
Yang, Jay
Brunner, Andrew M. http://orcid.org/0000-0002-2169-4115
Carraway, Hetty E.
Ades, Lionel http://orcid.org/0000-0002-9020-8766
Al-Kali, Aref http://orcid.org/0000-0002-0824-3715
Alonso-Dominguez, Juan M.
Alfonso-Piérola, Ana
Coombs, Catherine C.
Deeg, H. Joachim http://orcid.org/0000-0002-4426-9023
Flinn, Ian http://orcid.org/0000-0001-6724-290X
Foran, James M. http://orcid.org/0000-0003-1673-1708
Garcia-Manero, Guillermo http://orcid.org/0000-0002-3631-2482
Maris, Michael B.
McMasters, Malgorzata
Micol, Jean-Baptiste http://orcid.org/0000-0003-0934-294X
De Oteyza, Jaime Perez
Thol, Felicitas
Wang, Eunice S. http://orcid.org/0000-0002-8644-0968
Watts, Justin M.
Taylor, Justin http://orcid.org/0000-0003-4407-6325
Stone, Richard
Gourineni, Vikram
Marino, Alyssa J.
Yao, Huilan
Destenaves, Benoit
Yuan, Xiaobin
Yu, Kun
Dar, Sara
Ohanjanian, Lernik
Kuida, Keisuke
Xiao, Jianjun http://orcid.org/0000-0002-8469-6134
Scholz, Catherine
Gualberto, Antonio http://orcid.org/0000-0002-6590-839X
Platzbecker, Uwe http://orcid.org/0000-0003-1863-3239
Funding for this research was provided by:
H3 Biomedicine Inc
Article History
Received: 10 April 2021
Revised: 25 May 2021
Accepted: 11 June 2021
First Online: 25 June 2021
Competing interests
: <b>Steensma:</b><i>H3 Biomedicine:</i> Other: Research funding to institution, not investigator; <i>Pfizer:</i> Consultancy; <i>Aprea:</i> Research Funding; <i>Stemline:</i> Consultancy; <i>Arrowhead:</i> Equity Ownership; <i>Summer Road:</i> Consultancy; <i>Astex:</i> Consultancy; <i>Onconova:</i> Consultancy. <b>Wermke:</b><i>Novartis:</i> Honoraria, Research Funding. <b>Klimek:</b><i>NIH:</i> Research Funding; <i>Cycle for Survival:</i> Research Funding. <b>Greenberg:</b><i>Notable Labs:</i> Research Funding; <i>Celgene:</i> Research Funding; <i>Genentech:</i> Research Funding; <i>H3 Biotech:</i> Research Funding; <i>Aprea:</i> Research Funding; <i>Novartis:</i> Membership on an entity’s Board of Directors or advisory committees. <b>Font:</b><i>Celgene:</i> Consultancy, Membership on an entity’s Board of Directors or advisory committees, Speakers Bureau; <i>Pfizer:</i> Membership on an entity’s Board of Directors or advisory committees; <i>Novartis:</i> Membership on an entity’s Board of Directors or advisory committees, Speakers Bureau. <b>Komrokji:</b><i>Agios:</i> Consultancy; <i>JAZZ:</i> Speakers Bureau; <i>DSI:</i> Consultancy; <i>JAZZ:</i> Consultancy; <i>Incyte:</i> Consultancy; <i>Novartis:</i> Speakers Bureau; <i>Celgene:</i> Consultancy; <i>Pfizer:</i> Consultancy. <b>Yang:</b><i>Agios:</i> Consultancy; <i>AstraZeneca:</i> Research Funding. <b>Brunner:</b><i>Astra Zeneca:</i> Research Funding; <i>Celgene:</i> Membership on an entity’s Board of Directors or advisory committees, Research Funding; <i>Forty Seven Inc:</i> Membership on an entity’s Board of Directors or advisory committees; <i>Jazz Pharma:</i> Membership on an entity’s Board of Directors or advisory committees; <i>Novartis:</i> Membership on an entity’s Board of Directors or advisory committees, Research Funding. <b>Ades:</b><i>Agios:</i> Membership on an entity’s Board of Directors or advisory committees; <i>Helsinn Healthcare:</i> Membership on an entity’s Board of Directors or advisory committees; <i>Celgene:</i> Membership on an entity’s Board of Directors or advisory committees; <i>Novartis:</i> Membership on an entity’s Board of Directors or advisory committees; <i>Amgen:</i> Research Funding; <i>Jazz:</i> Membership on an entity’s Board of Directors or advisory committees; <i>Abbvie:</i> Membership on an entity’s Board of Directors or advisory committees; <i>Astellas:</i> Membership on an entity’s Board of Directors or advisory committees; <i>Silence Therapeutics:</i> Membership on an entity’s Board of Directors or advisory committees; <i>Takeda:</i> Membership on an entity’s Board of Directors or advisory committees. <b>Al-Kali:</b><i>H3 Biomedicine:</i> Other: Research funding; <i>Astex Pharmaceuticals, Inc.:</i> Research Funding. <b>Alonso-Dominguez:</b><i>Pfizer, Celgene, Incyte:</i> Research Funding. <b>Coombs:</b><i>AbbVie:</i> Consultancy and Honoraria; <i>LOXO</i>: Honoraria; <i>MEI Pharma</i>: Honoraria; <i>Octapharma</i>: Honoraria. <b>Foran:</b><i>Agios:</i> Honoraria, Research Funding. <b>Garcia-Manero:</b><i>Helsinn:</i> Research Funding; <i>Novartis:</i> Research Funding; <i>AbbVie:</i> Research Funding; <i>Celgene:</i> Consultancy, Research Funding; <i>Amphivena:</i> Consultancy, Research Funding; <i>Astex:</i> Consultancy, Research Funding; <i>Onconova:</i> Research Funding; <i>H3 Biomedicine:</i> Research Funding; <i>Merck:</i> Research Funding. <b>Micol:</b><i>AbbVie:</i> Consultancy; <i>Jazz Pharmaceuticals:</i> Consultancy. <b>Perez De Oteyza:</b><i>Celgene:</i> Speakers Bureau. <b>Wang:</b><i>Abbvie:</i> Other: Advisory role; <i>Kite:</i> Other: Advisory role; <i>Jazz:</i> Other: Advisory role; <i>Astellas:</i> Other: Advisory role, Speakers Bureau; <i>celyad:</i> Other: Advisory role; <i>Pfizer:</i> Other: Advisory role, Speakers Bureau; <i>Stemline:</i> Other: Advisory role, Speakers Bureau; <i>Daiichi:</i> Other: Advisory role; <i>Amgen:</i> Other: Advisory role; <i>Agios:</i> Other: Advisory role. <b>Watts:</b><i>Jazz Pharmaceuticals:</i> Membership on an entity’s Board of Directors or advisory committees; <i>Takeda:</i> Membership on an entity’s Board of Directors or advisory committees; Research Funding; <i>Rafael Pharmaceuticals:</i> Membership on an entity’s Board of Directors or advisory committees. <b>Gourineni:</b><i>H3 Biomedicine:</i> Employment. <b>Marino:</b><i>H3 Biomedicine:</i> Employment. <b>Yao:</b><i>H3 Biomedicine:</i> Employment. <b>Destenaves:</b><i>H3 Biomedicine:</i> Employment. <b>Yuan:</b><i>Eisai:</i> Employment. <b>Yu:</b><i>H3 Biomedicine:</i> Employment. <b>Dar</b>: <i>H3 Biomedicine:</i> Employment. <b>Ohanjanian:</b><i>H3 Biomedicine:</i> Employment. <b>Kuida:</b><i>H3 Biomedicine:</i> Employment. <b>Xiao:</b><i>H3 Biomedicine:</i> Employment. <b>Scholz:</b><i>H3 Biomedicine:</i> Employment. <b>Gualberto:</b><i>H3 Biomedicine:</i> Employment. <b>Platzbecker:</b><i>Abbvie:</i> Consultancy, Honoraria; <i>Novartis:</i> Consultancy, Honoraria, Research Funding; <i>Celgene:</i> Consultancy, Honoraria, Research Funding.